Vida Ventures, LLC bought KYTX
February 12, 2024 · Form 4 insider transaction
Vida Ventures, LLC bought 252,553 shares of Kyverna Therapeutics, Inc. at $22.00 per share, a transaction worth $5.56M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
The shares of the Issuer's Common Stock are held directly by Vida Ventures III, L.P. ("Vida III"). Vida Ventures GP III, L.L.C. ("Vida III GP") is the general partner of Vida III. Vida III GP disclaims beneficial ownership of the securities held by Vida III, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their pecuniary interest therein, if any.